Taylor Wessing advised Cumulus Oncology Cumulus Oncology on its exclusive GPR68 licence and development collaboration with leadXpro. Cumulus Oncology and leadXpro initiated a groundbreaking collaboration in...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Healx on its funding round. Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases based in Cambridge UK, has raised $47 million...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Essential Pharma on its acquisition of European rights to Colobreathe. International specialty pharmaceutical company, Essential Pharma, has acquired the European rights to Colobreathe...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised AlveoGene on its complex spinout and launch investment. AlveoGene, a newly established UK gene therapy company, has successfully completed a complex spinout from...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised World Fund and Ashurst advises CPT Capital. World Fund, a prominent climate venture capital fund, recently invested €40 million in ENOUGH, a food-tech...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics on its series C funding round. Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in...
You must be a Standard 1 Year member to access this content.
Linklaters and Allen & Overy advised global investment firms Carlyle and PAI Partners, while Latham & Watkins acted for CVC Capital Partners and Theramex. Taylor Wessing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised Current Health on the deal. Best Buy announced it had signed an agreement to acquire Current Health,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised WuXi AppTec on the deal. WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in...
You must be a Standard 1 Year member to access this content.
Philip Lee advised JSM on the investment. Taylor Wessing advised Rutland Partners. Private equity investor, Rutland Partners, has completed its investment in JSM Group, a UK-based...
You must be a Standard 1 Year member to access this content.
